This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. One of the most closely watched clinical trials in the ...

Shares of Compass Pathways PLC climbed on Friday after the U.S.-listed healthcare group announced a successful follow-up study of a psychedelic drug used to treat major depression in cancer patients.

52-week observational follow-up study from Phase 2b reveals single 25 mg COMP360 psilocybin dose offers longer-term antidepressant effects compared to lower doses, with average efficacy for a single ...

BOSTON, Jan. 06, 2023 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (“Compass”; Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based ...

CARLSBAD, Calif.--(BUSINESS WIRE)--Carlsmed ® announced today that the first patients have been enrolled in the COMPaSS™ study. COMPaSS, Clinical Outcome Measures in Personalized aprevo ® Spine ...

TORONTO--(BUSINESS WIRE)--Security Compass, a leading cybersecurity solution provider, has published the results of a research study examining developer views on application security, including the ...

The first patient was dosed in the Phase 1 dose escalation trial of CTX-8371.This study is conducted in patients with advanced solid tumors who progressed on at least one prior regimen containing a ...

With their strong sense of smell and unparalleled gift for tracking, dogs have sometimes been called “fur missiles,” and a recent study reveals another reason they may be so good at “homing” in.

Think twice about that granola bar in the morning because, yes you’re reading this correctly, ice cream may be a better option. A new study from Tufts University in Boston has created the “Food ...

Dogs can typically smell and hear far better than their human companions. Now it appears they can sense Earth’s magnetic field too, say a team of biologists – and they show it when they poop. These ...